The effect of Ginsenoside Rg1 on abnormal phosphorylation of tau in rat's hippocampal neurons induced by aggregated Aβ25-35

Chinese Pharmacological Bulletin

Volumn 21, Issue 3, 2005, Pages 299-305

  Peng, Xiao Song ^a   Chen, Xiao Chun ^a   Huang, Jun Shan ^a   Zhu, Yuan Gui ^a   Li, Yong Kun ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Ginsenoside Rg1; Glycogen synthase kinase 3 (GSK 3 ); Phosphorylation; Tau protein; amyloid protein25 35 (A 25 35)

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GINSENOSIDE RG 1; GLYCOGEN SYNTHASE KINASE 3BETA; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROINJECTION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STEREOTAXIC SURGERY; WESTERN BLOTTING;

EID: 22344434264     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Selkoe DJ. The molecular pathology of Alzheimers disease[J]. Neuron, 1991, 6(4):487-98.
2. Tagliavini F, Giaccone G, Frangione B et al. Preamyloid deposits in the cerebral cortex of patients with Alzheimers disease and nondemented individuals[J]. Neurosci Lett, 1988, 93(2-3):191-6.
3. Gong CX, Lidsky T, Wegiel J et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease[J]. J Bio Chem, 2000, 275(8):5535-44.
4. Butterfield DA, Howard B, Yatin S et al. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease[J]. Life Sci, 1999, 65(18-19):1883-92.
5. Kalman J, Engelhardt JI, Le WD et al. Experimental immune-mediated damage of septal cholinergic neurons[J]. J Neuroimmunol, 1997, 77(1):63-74.
6. Yatin SM, Aksenova M, Aksenov M et al. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses[J]. J Mol Neurosci, 1998, 11(3):183-97.
7. Arriagada PV, Growdon JH, Hedley-Whyte ET et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimers disease[J]. Neurology, 1992, 42(3pt1):631-9.
8. Sigurdsson EM, Lorens SA, Hejna MJ et al. Local and distant histopathological effects of unilateral amyloid-beta 25-35 injections into the amygdala of young F344 rats[J]. Neurobiol Aging, 1996, 17(6):893-901.
9. Leger J, Kempf M, Lee G et al. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau[J]. J Biol Chem, 1997, 272(13):8441-6.
10. Xie H, Litersky JM, Hartigan JA et al. The interrelationship between selective tau phosphorylation and microtubule association [J]. Brain Res, 1998, 798(1-2):173-83.
11. Wang XY, Chen J, Zhang JT. Effect of ginsenoside Rg1 on learning and memory impairment induced by β-amyloid peptide (25-35) and its mechanism of action[J]. Acta Pharma Sinica, 2001, 36(1):1-4.
12. Chen XC, Chen Y, Zhu YG et al. Protective effect of Ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons[J]. Acta Pharmacol Sin, 2002, 23(9):829-34.
13. Wang JZ, Gong CX, Zaidi T et al. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatases-2A and -2B[J]. J Biol Chem, 1995, 270(9):4854-60.
14. Tomidokoro Y, Ishiguro K, Harigaya Y et al. Abeta amyloidosis induces the initial stage of tau accumulation in APP (sw) mice [J]. Neurosci Lett, 2001, 299(3):169-72.